Is there an Indian generic version of Brigatinib?

Brigatinib/Brigatinib (Brigatinib) There are currently no Indian generic drugs on the market, mainly generic drugs in Bangladesh and Laos .

Brigatinib/Brigatinib has been launched in China and has been included in medical insurance. Since it has just been approved for marketing, patients may not be able to buy it in domestic pharmacies. If you need to purchase it in China, please consult the local pharmacy. However, the price is quite high, more than 10,000 yuan. Foreign Brigatinib/Brigatinib are mainly generic drugs, mainly Bangladeshi and Laos generic drugs. The price of the international version of the Bangladeshi generic drug Yaopin is about 2000yuan, the specification is 90mg*30 tablets; the price of the Laos version of the generic drug is about 600, and the specification is smaller. And the ingredients of domestic original drugs and foreign generic drugs are basically the same.

Brigatinib/Brigatinib has shown significant anti-tumor activity and good efficacy in clinical trials. It is approved for first-line treatment of patients with ALK fusion-positive NSCLC and for patients with NSCLC who have developed resistance to other ALK inhibitors. Brigatinib/Brigatinib can prolong the progression-free survival and overall survival of patients and reduce the risk of tumor progression.

Brigatinib/Brigatinib is usually supplied as an oral tablet and requires an individualized dosage and regimen based on the patient's specific condition and the recommendations of the physician.

Importantly,Brigatinib/Brigatinib is a prescription drug and should only be used under the supervision of a doctor. Currently usingbrigatinib/Before taking brigatinib, patients should consult a professional doctor for detailed medication instructions and follow the doctor’s recommendations for treatment.